BlackRock Health Sciences Term Trust (NYSE:BMEZ – Get Free Report) was the target of a large increase in short interest during the month of March. As of March 31st, there was short interest totaling 73,197 shares, an increase of 102.2% from the March 15th total of 36,205 shares. Based on an average daily trading volume, of 282,952 shares, the short-interest ratio is presently 0.3 days.
Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently made changes to their positions in BMEZ. Kestra Advisory Services LLC bought a new position in shares of BlackRock Health Sciences Term Trust in the fourth quarter valued at approximately $26,000. Geneos Wealth Management Inc. acquired a new stake in BlackRock Health Sciences Term Trust during the first quarter valued at approximately $40,000. Allworth Financial LP lifted its stake in BlackRock Health Sciences Term Trust by 24,584.6% during the third quarter. Allworth Financial LP now owns 3,209 shares of the company’s stock valued at $46,000 after purchasing an additional 3,196 shares during the last quarter. CWM LLC lifted its stake in BlackRock Health Sciences Term Trust by 25.6% during the fourth quarter. CWM LLC now owns 3,336 shares of the company’s stock valued at $50,000 after purchasing an additional 680 shares during the last quarter. Finally, Newbridge Financial Services Group Inc. acquired a new stake in BlackRock Health Sciences Term Trust during the second quarter valued at approximately $69,000.
BlackRock Health Sciences Term Trust Price Performance
Shares of NYSE:BMEZ traded up $0.32 during trading on Tuesday, reaching $14.78. 233,618 shares of the company’s stock traded hands, compared to its average volume of 274,408. BlackRock Health Sciences Term Trust has a 12 month low of $13.40 and a 12 month high of $15.80. The company has a 50 day moving average of $14.56 and a 200-day moving average of $14.90.
BlackRock Health Sciences Term Trust Announces Dividend
BlackRock Health Sciences Term Trust Company Profile
BlackRock Health Sciences Term Trust (NYSE: BMEZ) is a closed-end management investment company organized as a Delaware statutory trust. Launched in March 2020, BMEZ seeks to provide total return through a combination of current income and capital appreciation by investing primarily in equity and equity-related securities of companies in the health sciences sector. The trust is structured with a fixed termination date in October 2030, at which time shareholders will vote on its liquidation, extension or conversion.
The fund’s investment portfolio is diversified across subsectors within health sciences, including biotechnology, pharmaceuticals, medical devices, diagnostics and healthcare services.
Further Reading
Receive News & Ratings for BlackRock Health Sciences Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.
